302 related articles for article (PubMed ID: 19361352)
1. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.
Cho HJ; Cho HJ; Kim HS
Curr Atheroscler Rep; 2009 May; 11(3):206-13. PubMed ID: 19361352
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.
Scatena M; Liaw L; Giachelli CM
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2302-9. PubMed ID: 17717292
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin in Vascular Disease.
Lok ZSY; Lyle AN
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):613-622. PubMed ID: 30727754
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.
Wolak T
Atherosclerosis; 2014 Oct; 236(2):327-37. PubMed ID: 25128758
[TBL] [Abstract][Full Text] [Related]
5. Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis.
Shao JS; Sierra OL; Cohen R; Mecham RP; Kovacs A; Wang J; Distelhorst K; Behrmann A; Halstead LR; Towler DA
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1821-33. PubMed ID: 21597007
[TBL] [Abstract][Full Text] [Related]
6. The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)-A Narrative Review.
Kadoglou NPE; Khattab E; Velidakis N; Gkougkoudi E
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137398
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of vascular calcification: a bench to bedside view.
Dellegrottaglie S; Sanz J; Rajagopalan S
Curr Mol Med; 2006 Aug; 6(5):515-24. PubMed ID: 16918372
[TBL] [Abstract][Full Text] [Related]
8. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification.
Hirota S; Imakita M; Kohri K; Ito A; Morii E; Adachi S; Kim HM; Kitamura Y; Yutani C; Nomura S
Am J Pathol; 1993 Oct; 143(4):1003-8. PubMed ID: 8213995
[TBL] [Abstract][Full Text] [Related]
9. N-terminal rather than full-length osteopontin or its C-terminal fragment is associated with carotid-plaque inflammation in hypertensive patients.
Wolak T; Sion-Vardi N; Novack V; Greenberg G; Szendro G; Tarnovscki T; Nov O; Shelef I; Paran E; Rudich A
Am J Hypertens; 2013 Mar; 26(3):326-33. PubMed ID: 23382482
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin/SPP1: a potential mediator between immune cells and vascular calcification.
Zhao Y; Huang Z; Gao L; Ma H; Chang R
Front Immunol; 2024; 15():1395596. PubMed ID: 38919629
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo.
Speer MY; McKee MD; Guldberg RE; Liaw L; Yang HY; Tung E; Karsenty G; Giachelli CM
J Exp Med; 2002 Oct; 196(8):1047-55. PubMed ID: 12391016
[TBL] [Abstract][Full Text] [Related]
12. The multiple functions and mechanisms of osteopontin.
Icer MA; Gezmen-Karadag M
Clin Biochem; 2018 Sep; 59():17-24. PubMed ID: 30003880
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis.
Abdelaziz Mohamed I; Gadeau AP; Hasan A; Abdulrahman N; Mraiche F
Cells; 2019 Dec; 8(12):. PubMed ID: 31816901
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?
Strobescu-Ciobanu C; Giuşcă SE; Căruntu ID; Amălinei C; Rusu A; Cojocaru E; Popa RF; Lupaşcu CD
Rom J Morphol Embryol; 2020; 61(3):793-801. PubMed ID: 33817720
[TBL] [Abstract][Full Text] [Related]
15. Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice.
Grün NG; Strohmeier K; Moreno-Viedma V; Le Bras M; Landlinger C; Zeyda K; Wanko B; Leitner L; Staffler G; Zeyda M; Stulnig TM
Immunol Lett; 2016 Nov; 179():85-94. PubMed ID: 27639826
[TBL] [Abstract][Full Text] [Related]
16. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.
Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H
Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
Pedersen TX; Madsen M; Junker N; Christoffersen C; Vikeså J; Bro S; Hultgårdh-Nilsson A; Nielsen LB
Cardiovasc Res; 2013 Jun; 98(3):352-9. PubMed ID: 23455547
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin regulates macrophage activation and osteoclast formation in hypertensive patients with vascular calcification.
Ge Q; Ruan CC; Ma Y; Tang XF; Wu QH; Wang JG; Zhu DL; Gao PJ
Sci Rep; 2017 Jan; 7():40253. PubMed ID: 28091516
[TBL] [Abstract][Full Text] [Related]
19. Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.
Qi S; Huang G; Pan J; Li J; Zhang X; Fang L; Liu B; Meng W; Zhang Y; Liu X
J Neurooncol; 2010 May; 98(1):21-30. PubMed ID: 19902145
[TBL] [Abstract][Full Text] [Related]
20. Soluble osteopontin and vascular calcification in hemodialysis patients.
Nitta K; Ishizuka T; Horita S; Hayashi T; Ajiro A; Uchida K; Honda K; Oba T; Kawashima A; Yumura W; Kabaya T; Akiba T; Nihei H
Nephron; 2001 Dec; 89(4):455-8. PubMed ID: 11721165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
